Adjuvant Therapy for Improved Acute Otitis Media Outcomes in Infants

Acute otitis media, a common childhood disease, often leads to hearing loss in children. Despite the existence of effective antibiotics, treatment failures, persistent fluid buildup, and recurrences are common. This study focuses on infants under one year old, aiming to improve their acute and long-term outcomes. The research explores if adding adjuvant therapy, either an antihistamine or a corticosteroid, to antibiotic treatment can enhance recovery. This could potentially address current challenges in treatment, providing a more effective solution for this condition. During this Phase III study, participants receive both antibiotic therapy and either an antihistamine or a corticosteroid. The study lasts for one year after enrollment. The impact of this combined treatment approach is evaluated to determine if it reduces treatment failures, persistent fluid buildup, and recurrences. By testing this new approach, the study hopes to find a more reliable treatment for acute otitis media in infants.